In the study conducted by Hassan et al., elevated serum IL-17 levels were observed in patients with end-stage liver disease who had invasive fungal infections, particularly Aspergillus infections (present in 41.67% of cases), compared to those with non-invasive fungal infections. The gene discussed is IL17A; the disease is End Stage Liver Disease.